Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • NHS Solutions
  • Life Sciences Industry
  • Advancing UK Healthcare
  • Pharmacy Communications
NHS Solutions

Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.

Learn More
NHS Solutions
Life Sciences Industry

We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.

Learn More
Life Sciences Industry Solutions
Advancing UK Healthcare

We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.

Learn More
Advancing UK Healthcare Solutions
Pharmacy Communications

IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.

Learn More
MAIN/Insights
Insights/
BLOGS, WHITEPAPERS & CASE STUDIES

Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.

Learn More
NEWSROOM

Stay up to date on the latest news and press releases from IQVIA UK & Ireland.

Learn More

Report

"Our commitment to sustainability.

Learn More
MAIN/Contact Us
Contact Us/

Press Release

Pharmacist-led services connect the pharmaceutical industry with primary care

Nov 05, 2020

The right treatment at the right time to the right patient

In an ever-changing health economy, with tightening regulations and a focus on cost effectiveness, a thorough understanding of the healthcare environment and a well-considered market access strategy are vital for pharma to effectively communicate their service offering.

This ensures products and services are delivered to the right people and in the right way, at the right time. Most importantly, it allows patients struggling with conditions to access treatments and medicines capable of improving their health.

Bridging the gap between the NHS and pharmaceutical companies

Interface Clinical Services, an IQVIA business, deliver clinical review services to primary care through a nationwide team of clinical pharmacists. It enables the pharmaceutical industry to effectively engage with the NHS and the wider healthcare environment. It also helps:

  • Identify gaps in service provision and specific treatment needs within a patient population
  • Manage high-risk patients, including recommending patients for medicinal and non-medicinal interventions where appropriate
  • Provide the NHS with increased clinical resources
  • Focus resource and maximise the strategic benefit
  • Support product launch and growth strategies for pharmaceutical companies

Case study: Improving high-risk asthmatic patients’ treatments and outcomes

The Interface Clinical Services team delivered a clinical review of high-risk asthmatic patients across a Health Care Partnership spanning 52 medical practices. 13 pharmacists supported over 18,000 NHS patients over 4 months. Patients benefited from 5,488 medicinal interventions, including 1,582 patients who were initiated on a treatment. 59% of patients invited, attended pharmacist-led clinics and received personalised guidance and education.

In a COVID-19 environment, this clinical review enabled the Health Care Partnership to:

  • Provide additional support to patients with respiratory conditions and ensure they continue to receive the care they need
  • Ensure that asthmatic patients were supported to achieve optimal management
  • Protect vulnerable patients, ensure continuity of care and prevent non-COVID related, unplanned primary and secondary care encounters
Contact Us